FDA lifts pause on Novavax flu vaccine trials
After an investigation, the agency concluded that a case of muscle weakness in one of Novavax’s trials was actually ALS and ...
Indiatimes2h
US FDA lifts clinical hold on Novavax's combo Covid-flu shot
The US Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...
Novavax to Report Q3 Earnings: Here's What to Expect
On NVAX's third-quarter earnings call, investors will likely seek updates on management???s ongoing discussions with the FDA ...
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold — Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
Hosted on MSN3h
Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot
Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s ...
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...
Seeking Alpha4h
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza Combination ...
Benzinga.com5h
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
Novavax will be working with the clinical trial investigators and other partners to resume trial activities as quickly as possible. In October, the FDA issued the clinical hold due to a spontaneous ...
MedPage Today2d
When's the Best Time to Get Your Flu and COVID Shots?
Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters -- they're not just another dose of ...
bovnews3d
Novavax Inc (NVAX) Stock Sees Market Value Hit $1.47 billion: What Are the Implications?
On Thursday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.18 which represents a slight increase of $0.22 or 2.46% from the prior close of $8.96. The stock opened at $9.16 and ...